 Rose Gelineau-Morel
Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystonia | 3 | 2023 | 7 | 2.740 |
Why?
| | Dystonic Disorders | 3 | 2023 | 4 | 2.000 |
Why?
| | Cerebral Palsy | 3 | 2023 | 16 | 2.000 |
Why?
| | Kernicterus | 2 | 2023 | 7 | 1.770 |
Why?
| | Motor Disorders | 2 | 2023 | 3 | 1.140 |
Why?
| | Disabled Persons | 2 | 2023 | 5 | 1.140 |
Why?
| | Neurology | 2 | 2022 | 10 | 1.000 |
Why?
| | Pandemics | 2 | 2022 | 78 | 0.950 |
Why?
| | Hyperbilirubinemia, Neonatal | 1 | 2023 | 6 | 0.940 |
Why?
| | Deep Brain Stimulation | 1 | 2022 | 1 | 0.890 |
Why?
| | Movement Disorders | 1 | 2022 | 4 | 0.890 |
Why?
| | Humans | 16 | 2023 | 6599 | 0.860 |
Why?
| | Research Personnel | 1 | 2021 | 4 | 0.850 |
Why?
| | Education, Nursing, Continuing | 1 | 2021 | 3 | 0.800 |
Why?
| | Education, Medical, Continuing | 1 | 2021 | 6 | 0.800 |
Why?
| | User-Computer Interface | 1 | 2021 | 10 | 0.800 |
Why?
| | Education, Distance | 1 | 2021 | 5 | 0.790 |
Why?
| | Child | 10 | 2023 | 3146 | 0.600 |
Why?
| | Brain | 2 | 2013 | 74 | 0.500 |
Why?
| | Nerve Fibers, Myelinated | 2 | 2013 | 4 | 0.450 |
Why?
| | Bilirubin | 2 | 2023 | 25 | 0.450 |
Why?
| | Nerve Fibers, Unmyelinated | 1 | 2011 | 1 | 0.420 |
Why?
| | Multiple Sclerosis | 1 | 2011 | 18 | 0.410 |
Why?
| | Treatment Outcome | 3 | 2023 | 624 | 0.410 |
Why?
| | Infant, Newborn | 3 | 2023 | 790 | 0.400 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 290 | 0.380 |
Why?
| | Cyprinodontiformes | 1 | 2009 | 1 | 0.360 |
Why?
| | Sexual Behavior, Animal | 1 | 2009 | 1 | 0.360 |
Why?
| | Reproduction | 1 | 2009 | 7 | 0.360 |
Why?
| | Oxygen Consumption | 1 | 2009 | 18 | 0.360 |
Why?
| | Energy Metabolism | 1 | 2009 | 26 | 0.350 |
Why?
| | Adult | 4 | 2022 | 1233 | 0.300 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 114 | 0.290 |
Why?
| | Nigeria | 1 | 2023 | 3 | 0.240 |
Why?
| | Biomarkers | 1 | 2023 | 120 | 0.230 |
Why?
| | Spasms, Infantile | 1 | 2022 | 2 | 0.210 |
Why?
| | Female | 7 | 2022 | 3436 | 0.210 |
Why?
| | Algorithms | 1 | 2022 | 103 | 0.210 |
Why?
| | Internship and Residency | 1 | 2022 | 31 | 0.210 |
Why?
| | Prospective Studies | 1 | 2023 | 508 | 0.210 |
Why?
| | Infant | 2 | 2023 | 1396 | 0.210 |
Why?
| | Rare Diseases | 1 | 2022 | 37 | 0.200 |
Why?
| | Hospital Departments | 1 | 2021 | 1 | 0.200 |
Why?
| | Consumer Behavior | 1 | 2021 | 4 | 0.200 |
Why?
| | Personnel, Hospital | 1 | 2021 | 6 | 0.200 |
Why?
| | Curriculum | 1 | 2021 | 19 | 0.200 |
Why?
| | Genomics | 1 | 2022 | 86 | 0.200 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2020 | 9 | 0.190 |
Why?
| | Failure to Thrive | 1 | 2020 | 7 | 0.190 |
Why?
| | Male | 6 | 2022 | 3197 | 0.190 |
Why?
| | Risk Factors | 1 | 2021 | 460 | 0.190 |
Why?
| | Return to Sport | 1 | 2019 | 2 | 0.180 |
Why?
| | Intracranial Hypertension | 1 | 2019 | 2 | 0.180 |
Why?
| | Post-Concussion Syndrome | 1 | 2019 | 2 | 0.180 |
Why?
| | Athletic Injuries | 1 | 2019 | 3 | 0.180 |
Why?
| | Rest | 1 | 2019 | 4 | 0.180 |
Why?
| | Trauma Severity Indices | 1 | 2019 | 15 | 0.180 |
Why?
| | Risk Reduction Behavior | 1 | 2019 | 14 | 0.180 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 74 | 0.180 |
Why?
| | Hospitals, Pediatric | 1 | 2021 | 178 | 0.180 |
Why?
| | Referral and Consultation | 1 | 2019 | 33 | 0.180 |
Why?
| | Child Abuse | 1 | 2019 | 45 | 0.170 |
Why?
| | Retrospective Studies | 2 | 2021 | 1251 | 0.170 |
Why?
| | Middle Aged | 3 | 2013 | 648 | 0.130 |
Why?
| | Epilepsy, Rolandic | 1 | 2015 | 1 | 0.130 |
Why?
| | Child Behavior Disorders | 1 | 2015 | 6 | 0.130 |
Why?
| | Cognition Disorders | 1 | 2015 | 13 | 0.130 |
Why?
| | Child Behavior | 1 | 2015 | 30 | 0.130 |
Why?
| | Amiloride | 1 | 2013 | 1 | 0.110 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2013 | 1 | 0.110 |
Why?
| | Acid Sensing Ion Channels | 1 | 2013 | 1 | 0.110 |
Why?
| | Acid Sensing Ion Channel Blockers | 1 | 2013 | 1 | 0.110 |
Why?
| | Neuroprotective Agents | 1 | 2013 | 3 | 0.110 |
Why?
| | Axons | 1 | 2011 | 2 | 0.100 |
Why?
| | Atrophy | 1 | 2011 | 6 | 0.100 |
Why?
| | Organ Size | 1 | 2011 | 13 | 0.100 |
Why?
| | Brain Mapping | 1 | 2011 | 10 | 0.100 |
Why?
| | Disease Progression | 1 | 2011 | 104 | 0.100 |
Why?
| | Pedigree | 2 | 2022 | 53 | 0.100 |
Why?
| | Tourette Syndrome | 1 | 2010 | 6 | 0.100 |
Why?
| | Swimming | 1 | 2009 | 1 | 0.090 |
Why?
| | Body Size | 1 | 2009 | 7 | 0.090 |
Why?
| | Sex Characteristics | 1 | 2009 | 13 | 0.090 |
Why?
| | Phenotype | 1 | 2009 | 233 | 0.080 |
Why?
| | Genotype | 1 | 2009 | 395 | 0.080 |
Why?
| | Animals | 1 | 2009 | 563 | 0.080 |
Why?
| | Genome | 1 | 2022 | 30 | 0.050 |
Why?
| | Mothers | 1 | 2022 | 37 | 0.050 |
Why?
| | Anxiety | 1 | 2022 | 45 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2022 | 106 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2013 | 150 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 94 | 0.050 |
Why?
| | Aged | 2 | 2013 | 375 | 0.050 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 317 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 2087 | 0.050 |
Why?
| | Mutation | 1 | 2020 | 194 | 0.040 |
Why?
| | Anticonvulsants | 1 | 2015 | 25 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2013 | 23 | 0.030 |
Why?
| | Pilot Projects | 1 | 2013 | 124 | 0.030 |
Why?
| | Tics | 1 | 2010 | 1 | 0.020 |
Why?
| | Obsessive-Compulsive Disorder | 1 | 2010 | 6 | 0.020 |
Why?
| | Age of Onset | 1 | 2010 | 27 | 0.020 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 17 | 0.020 |
Why?
| | Child, Preschool | 1 | 2015 | 1459 | 0.020 |
Why?
| | Age Factors | 1 | 2010 | 203 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|